Evaluation of Results in Liver Transplantation with Ultrafast Technic Harvesting in Non-Heart-Beating Donors (Maastricht II and III): An Analysis of a Large Single-Center ExperienceAlejandra Garcia Novoa1*, Nicolasa Fernandez Soria1, Jose Ignacio Rivas Polo1, Alejandra Otero Ferreiro2, Ignacio Rey Simo2, Antón Fernandez García3, Javier Aguirrezabalaga Gonzalez3 and Manuel Gomez Gutiérrez3
- *Corresponding Author:
- Alejandra García Novoa
Calle Atocha Baja 3, Bajo cubierta B (6ºB)
A Coruña, Coruña, 15001, Spain
Tel: 0034 674089387
E-mail: [email protected]
Received date: January 20, 2016; Accepted date: Feburary 15, 2016; Published date: Feburary 22, 2016
Citation: Novoa AG, Soria NF, Polo JIR, Ferreiro AO, Simo IR, et al. (2016) Evaluation of Results in Liver Transplantation with Ultrafast Technic Harvesting in Non-Heart-Beating Donors (Maastricht II and III): An Analysis of a Large Single-Center Experience. J Gastrointest Dig Syst 6:391. doi:10.4172/2161-069X.1000391
Copyright: © 2016 Novoa AG, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Objective: To determine the viability of liver graft obtained from NHBD Maastricht II and III and long-term recipients survival. Material and Methods: Retrospective study of LT performed with en bloc technique for abdominal organ harvesting in NHBD in our hospital from December 1995 to January 2015. Results: 25 cases were performed: 17 Maastricht category II and 8 cases category III. Maastricht II. With a mean follow-up of 91.36 months (0,5-211m) one year recipient survival was 82.35% and 70.6% at 5 years. Liver graft survival was 70.6% and 64.7% at one year and five years, respectively. None of deaths during follow-up was secondary to graft failure. 3 patients were retransplanted: 2 were urgently for PAF and one at 3 years for HBV. Maastricht III. With a mean follow up of 14.67 months one year recipient survival was 100% and 88,9% of the graft survival. Two retransplantation were performed: one urgent for "small for size" and another at 18 months because of ischemic cholangitis. Conclusions: Grafts from NHBD allows acceptable results in terms of patient and graft survival.